No insider purchase over the last 90 days. The latest was filed 23 Mar 2026.
This page follows insider dealings at Tristel plc as filed with RNS (LSE). The last twelve months, up to 18 October 2026, brought 1 filing signed by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase totalling €12k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €12k from Caroline Stephens, disclosed on 23 March 2026. The buyers include 1 board member.
Compared with its exchange (833 companies, median 6 filings), a count of 1 filing is below the norm. Over the whole record (from 2023), the tally stands at 4 purchases and 7 sales.
The clock since the last published purchase (23 March 2026) now reads 209 days.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Tristel plc Strong Buy (bullish), based on 6 analysts. Average price target: £4.75.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2025 · cache
11 of 11 declarations
Tristel plc is a UK-based company specializing in disinfection and cleaning products for the healthcare sector. It develops innovative solutions to ensure patient safety and infection prevention.